Advertisement
U.S. markets closed

CorMedix Inc. (CRMD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
4.2400+0.0800 (+1.92%)
At close: 04:00PM EDT
4.2800 +0.04 (+0.94%)
After hours: 07:11PM EDT

CorMedix Inc.

300 Connell Drive
Suite 4200
Berkeley Heights, NJ 07922
United States
908 517 9500
https://www.cormedix.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees82

Key Executives

NameTitlePayExercisedYear Born
Mr. Joseph Todisco MBACEO & Director1.07MN/A1977
Dr. Matthew T. David M.D.Executive VP & CFO597.27kN/A1979
Ms. Erin MistryExecutive VP & Chief Commercial Officer561.57kN/A1983
Ms. Elizabeth Masson-Hurlburt B.A.Executive VP and Chief Clinical Strategy & Operations Officer538.91kN/A1980
Ms. Kaufman Beth Zelnick Esq.Executive VP, Chief Legal Officer & Corporate SecretaryN/AN/AN/A
Donna UcciSenior VP & Head of Global QualityN/AN/AN/A
Dr. Tushar MukherjeeSenior VP & Head of Technical OperationsN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Corporate Governance

CorMedix Inc.’s ISS Governance QualityScore as of March 1, 2024 is 5. The pillar scores are Audit: 6; Board: 6; Shareholder Rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.